ImmunOs Therapeutics AG has raised financing from top-tier investors such as Pfizer Ventures, BioMed Partners, Redalpine, Schroder Adveq, Wille Finance AG, BERNINA BioInvest Ltd, UZH Life Sciences Fund and undisclosed private investors.

The Company has built a preclinical portfolio of novel immunotherapy candidates and is currently exploring strategic collaborations with leading global pharmaceutical companies.